001     163477
005     20240722111357.0
024 7 _ |a pmc:PMC9211765
|2 pmc
024 7 _ |a 10.3233/JPD-212851
|2 doi
024 7 _ |a pmid:34633332
|2 pmid
024 7 _ |a 1877-7171
|2 ISSN
024 7 _ |a 1877-718X
|2 ISSN
024 7 _ |a altmetric:114986987
|2 altmetric
037 _ _ |a DZNE-2022-00237
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Domenighetti, Cloé
|b 0
245 _ _ |a Mendelian Randomisation Study of Smoking, Alcohol, and Coffee Drinking in Relation to Parkinson's Disease.
260 _ _ |a Amsterdam
|c 2022
|b IOS Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1721639608_12034
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Previous studies showed that lifestyle behaviors (cigarette smoking, alcohol, coffee) are inversely associated with Parkinson's disease (PD). The prodromal phase of PD raises the possibility that these associations may be explained by reverse causation.To examine associations of lifestyle behaviors with PD using two-sample Mendelian randomisation (MR) and the potential for survival and incidence-prevalence biases.We used summary statistics from publicly available studies to estimate the association of genetic polymorphisms with lifestyle behaviors, and from Courage-PD (7,369 cases, 7,018 controls; European ancestry) to estimate the association of these variants with PD. We used the inverse-variance weighted method to compute odds ratios (ORIVW) of PD and 95%confidence intervals (CI). Significance was determined using a Bonferroni-corrected significance threshold (p = 0.017).We found a significant inverse association between smoking initiation and PD (ORIVW per 1-SD increase in the prevalence of ever smoking = 0.74, 95%CI = 0.60-0.93, p = 0.009) without significant directional pleiotropy. Associations in participants ≤67 years old and cases with disease duration ≤7 years were of a similar size. No significant associations were observed for alcohol and coffee drinking. In reverse MR, genetic liability toward PD was not associated with smoking or coffee drinking but was positively associated with alcohol drinking.Our findings are in favor of an inverse association between smoking and PD that is not explained by reverse causation, confounding, and survival or incidence-prevalence biases. Genetic liability toward PD was positively associated with alcohol drinking. Conclusions on the association of alcohol and coffee drinking with PD are hampered by insufficient statistical power.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a Mendelian randomisation
|2 Other
650 _ 7 |a Parkinson’s disease
|2 Other
650 _ 7 |a Smoking
|2 Other
650 _ 7 |a alcohol
|2 Other
650 _ 7 |a coffee
|2 Other
650 _ 2 |a Aged
|2 MeSH
650 _ 2 |a Alcohol Drinking: epidemiology
|2 MeSH
650 _ 2 |a Alcohol Drinking: genetics
|2 MeSH
650 _ 2 |a Coffee
|2 MeSH
650 _ 2 |a Genome-Wide Association Study
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Mendelian Randomization Analysis
|2 MeSH
650 _ 2 |a Parkinson Disease: etiology
|2 MeSH
650 _ 2 |a Parkinson Disease: genetics
|2 MeSH
650 _ 2 |a Risk Factors
|2 MeSH
650 _ 2 |a Smoking: epidemiology
|2 MeSH
700 1 _ |a Sugier, Pierre-Emmanuel
|b 1
700 1 _ |a Sreelatha, Ashwin Ashok Kumar
|b 2
700 1 _ |a Schulte, Claudia
|0 P:(DE-2719)9000366
|b 3
|u dzne
700 1 _ |a Grover, Sandeep
|b 4
700 1 _ |a Mohamed, Océane
|b 5
700 1 _ |a Portugal, Berta
|b 6
700 1 _ |a May, Patrick
|b 7
700 1 _ |a Bobbili, Dheeraj R
|b 8
700 1 _ |a Radivojkov-Blagojevic, Milena
|b 9
700 1 _ |a Lichtner, Peter
|b 10
700 1 _ |a Singleton, Andrew B
|b 11
700 1 _ |a Hernandez, Dena Michelle Godwin
|0 P:(DE-2719)2812102
|b 12
|u dzne
700 1 _ |a Edsall, Connor
|b 13
700 1 _ |a Mellick, George D
|b 14
700 1 _ |a Zimprich, Alexander
|b 15
700 1 _ |a Pirker, Walter
|b 16
700 1 _ |a Rogaeva, Ekaterina
|b 17
700 1 _ |a Lang, Anthony E
|b 18
700 1 _ |a Koks, Sulev
|b 19
700 1 _ |a Taba, Pille
|b 20
700 1 _ |a Lesage, Suzanne
|b 21
700 1 _ |a Brice, Alexis
|b 22
700 1 _ |a Corvol, Jean-Christophe
|b 23
700 1 _ |a Chartier-Harlin, Marie-Christine
|b 24
700 1 _ |a Mutez, Eugénie
|b 25
700 1 _ |a Brockmann, Kathrin
|0 P:(DE-2719)2811916
|b 26
|u dzne
700 1 _ |a Deutschländer, Angela B
|b 27
700 1 _ |a Hadjigeorgiou, Georges M
|b 28
700 1 _ |a Dardiotis, Efthimos
|b 29
700 1 _ |a Stefanis, Leonidas
|b 30
700 1 _ |a Simitsi, Athina Maria
|b 31
700 1 _ |a Valente, Enza Maria
|b 32
700 1 _ |a Petrucci, Simona
|b 33
700 1 _ |a Duga, Stefano
|b 34
700 1 _ |a Straniero, Letizia
|b 35
700 1 _ |a Zecchinelli, Anna
|b 36
700 1 _ |a Pezzoli, Gianni
|b 37
700 1 _ |a Brighina, Laura
|b 38
700 1 _ |a Ferrarese, Carlo
|b 39
700 1 _ |a Annesi, Grazia
|b 40
700 1 _ |a Quattrone, Andrea
|b 41
700 1 _ |a Gagliardi, Monica
|b 42
700 1 _ |a Matsuo, Hirotaka
|b 43
700 1 _ |a Kawamura, Yusuke
|b 44
700 1 _ |a Hattori, Nobutaka
|b 45
700 1 _ |a Nishioka, Kenya
|b 46
700 1 _ |a Chung, Sun Ju
|b 47
700 1 _ |a Kim, Yun Joong
|b 48
700 1 _ |a Kolber, Pierre
|b 49
700 1 _ |a van de Warrenburg, Bart Pc
|b 50
700 1 _ |a Bloem, Bastiaan R
|b 51
700 1 _ |a Aasly, Jan
|b 52
700 1 _ |a Toft, Mathias
|b 53
700 1 _ |a Pihlstrøm, Lasse
|b 54
700 1 _ |a Guedes, Leonor Correia
|b 55
700 1 _ |a Ferreira, Joaquim J
|b 56
700 1 _ |a Bardien, Soraya
|b 57
700 1 _ |a Carr, Jonathan
|b 58
700 1 _ |a Tolosa, Eduardo
|b 59
700 1 _ |a Ezquerra, Mario
|b 60
700 1 _ |a Pastor, Pau
|b 61
700 1 _ |a Diez-Fairen, Monica
|b 62
700 1 _ |a Wirdefeldt, Karin
|b 63
700 1 _ |a Pedersen, Nancy L
|b 64
700 1 _ |a Ran, Caroline
|b 65
700 1 _ |a Belin, Andrea C
|b 66
700 1 _ |a Puschmann, Andreas
|b 67
700 1 _ |a Hellberg, Clara
|b 68
700 1 _ |a Clarke, Carl E
|b 69
700 1 _ |a Morrison, Karen E
|b 70
700 1 _ |a Tan, Manuela
|b 71
700 1 _ |a Krainc, Dimitri
|b 72
700 1 _ |a Burbulla, Lena F.
|0 P:(DE-2719)9000040
|b 73
|u dzne
700 1 _ |a Farrer, Matt J
|b 74
700 1 _ |a Krüger, Rejko
|0 P:(DE-2719)2811170
|b 75
|u dzne
700 1 _ |a Gasser, Thomas
|0 P:(DE-2719)2320009
|b 76
|u dzne
700 1 _ |a Sharma, Manu
|0 P:(DE-2719)9000296
|b 77
|u dzne
700 1 _ |a Elbaz, Alexis
|b 78
700 1 _ |a Genetics, Comprehensive Unbiaised Risk Factor Assessment for
|b 79
700 1 _ |a Disease, Environment in Parkinson’s
|b 80
|e Collaboration Author
773 _ _ |a 10.3233/JPD-212851
|g Vol. 12, no. 1, p. 267 - 282
|0 PERI:(DE-600)2599550-9
|n 1
|p 267 - 282
|t Journal of Parkinson's Disease
|v 12
|y 2022
|x 1877-718X
856 4 _ |u https://pub.dzne.de/record/163477/files/DZNE-2022-00237_Restricted.pdf
856 4 _ |u https://pub.dzne.de/record/163477/files/DZNE-2022-00237_Restricted.pdf?subformat=pdfa
|x pdfa
909 C O |p VDB
|o oai:pub.dzne.de:163477
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 3
|6 P:(DE-2719)9000366
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 12
|6 P:(DE-2719)2812102
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 26
|6 P:(DE-2719)2811916
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 73
|6 P:(DE-2719)9000040
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 75
|6 P:(DE-2719)2811170
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 76
|6 P:(DE-2719)2320009
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 77
|6 P:(DE-2719)9000296
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2022
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-01-28
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-01-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-25
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J PARKINSON DIS : 2021
|d 2022-11-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2022-11-25
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2022-11-25
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b J PARKINSON DIS : 2021
|d 2022-11-25
920 1 _ |0 I:(DE-2719)5000055
|k AG Berg ; AG Berg
|l Parkinson's Disease Genetics
|x 0
920 1 _ |0 I:(DE-2719)1210000
|k AG Gasser
|l Parkinson Genetics
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)5000055
980 _ _ |a I:(DE-2719)1210000
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21